PACB Pacific Biosciences of California Inc.

PacBio to Present at Upcoming Investor Conferences

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conferences:

  • 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022, at 3:00 pm Eastern Time (12:00 pm Pacific Time)
  • Cowen 42nd Annual Health Care Conference on March 7, 2022, at 1:30 pm Eastern Time (10:30 am Pacific Time)

The live webcasts can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcasts will be available for at least 30 days following the presentation.

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate sequencing platforms. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit and follow .

Contacts

Investors:

Todd Friedman

650.521.8450

Media:

Kathy Lynch



EN
09/02/2022

Underlying

PACBPacific Biosciences of California Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pacific Biosciences of California Inc.

 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Da...

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research Collaboration powers secure international data sharing through the HiFi Solves Global Consortium MENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowi...

February 24, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio to Participate in the TD Cowen 46th Annual Health Care Conferen...

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference  MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026, at 2:30 PM ET in Boston, MA. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event. ...

February 18, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

PacBio Announces Fourth Quarter and Full Year 2025 Financial Results MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results:  Q4 2025Q4 2024FY 2025FY 2024Revenue (in millions)$44.6$39.2$160.0$154.0Consumable revenue (in millions)$21.6$18.8$82.0$70.3Instrument revenue (in millions)$17.3$15.3$53.8$65.8Service and other revenue (in millions)$5.7$5.1$24.2$17.9RevioTM system placements21236197VegaTM system placements4271407Annualized Revio pul...

February 12, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Pa...

PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s international network. iHope operates the world’s largest eq...

February 12, 2026 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Completes Sale of Short-Read Sequencing Assets

PacBio Completes Sale of Short-Read Sequencing Assets MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and gr...

February 2, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch